Fredun Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
406.23 Cr.
|
P/BV
|
4.21
|
Book Value (Rs.)
|
206.95
|
52 Week High/Low (Rs.)
|
1249/650
|
FV/ML
|
10/1
|
P/E(X)
|
26.00
|
Bookclosure
|
18/01/2024
|
EPS (Rs.)
|
33.50
|
Div Yield (%)
|
0.08
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 33.32 | 24.13 | 11.28 | 5.05 | 4.77 |
Diluted EPS (Rs.) | 33.32 | 24.13 | 11.28 | 5.05 | 4.77 |
Cash EPS (Rs.) | 41.32 | 30.04 | 19.16 | 10.07 | 9.48 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 258.49 | 212.64 | 153.54 | 107.96 | 103.57 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 258.49 | 212.64 | 153.54 | 107.96 | 103.57 |
Dividend / Share (Rs.) | 0.70 | 0.70 | 0.70 | 0.70 | 0.66 |
Revenue From Operations / Share (Rs.) | 742.83 | 606.04 | 506.38 | 335.60 | 282.66 |
PBDIT / Share (Rs.) | 82.78 | 65.31 | 34.80 | 26.41 | 22.02 |
PBIT / Share (Rs.) | 74.70 | 59.11 | 29.93 | 21.39 | 17.32 |
PBT / Share (Rs.) | 45.65 | 38.63 | 19.40 | 8.04 | 6.25 |
Net Profit / Share (Rs.) | 33.25 | 23.84 | 14.29 | 5.05 | 4.77 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 11.14 | 10.77 | 6.87 | 7.86 | 7.79 |
PBIT Margin (%) | 10.05 | 9.75 | 5.91 | 6.37 | 6.12 |
PBT Margin (%) | 6.14 | 6.37 | 3.83 | 2.39 | 2.21 |
Net Profit Margin (%) | 4.47 | 3.93 | 2.82 | 1.50 | 1.68 |
Return on Networth / Equity (%) | 12.86 | 11.21 | 9.30 | 4.67 | 4.60 |
Return on Capital Employeed (%) | 26.36 | 17.72 | 11.71 | 11.35 | 12.47 |
Return On Assets (%) | 5.07 | 4.20 | 3.38 | 1.24 | 1.42 |
Long Term Debt / Equity (X) | 0.04 | 0.50 | 0.61 | 0.67 | 0.27 |
Total Debt / Equity (X) | 0.86 | 0.89 | 0.77 | 0.92 | 0.84 |
Asset Turnover Ratio (%) | 1.24 | 1.24 | 1.29 | 0.90 | 0.94 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.47 | 2.04 | 2.07 | 1.50 | 1.30 |
Quick Ratio (X) | 0.47 | 0.62 | 1.44 | 0.72 | 0.65 |
Inventory Turnover Ratio (X) | 1.75 | 2.51 | 3.11 | 1.71 | 1.88 |
Dividend Payout Ratio (NP) (%) | 0.00 | 2.88 | 4.89 | 13.30 | 0.00 |
Dividend Payout Ratio (CP) (%) | 0.00 | 2.28 | 3.65 | 6.67 | 0.00 |
Earning Retention Ratio (%) | 0.00 | 97.12 | 95.11 | 86.70 | 0.00 |
Cash Earning Retention Ratio (%) | 0.00 | 97.72 | 96.35 | 93.33 | 0.00 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 2.85 | 3.19 | 3.30 | 2.53 | 1.99 |
Interest Coverage Ratio (Post Tax) (%) | 2.14 | 2.16 | 2.36 | 1.76 | 1.43 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 441.23 | 435.36 | 456.41 | 223.45 | 78.34 |
EV / Net Operating Revenue (X) | 1.26 | 1.59 | 2.03 | 1.67 | 0.69 |
EV / EBITDA (X) | 11.34 | 14.71 | 29.59 | 21.21 | 8.92 |
MarketCap / Net Operating Revenue (X) | 0.96 | 1.28 | 1.81 | 1.38 | 0.41 |
Retention Ratios (%) | 0.00 | 97.11 | 95.10 | 86.69 | 0.00 |
Price / BV (X) | 2.77 | 3.66 | 5.96 | 4.29 | 1.13 |
Price / Net Operating Revenue (X) | 0.96 | 1.28 | 1.81 | 1.38 | 0.41 |
EarningsYield | 0.04 | 0.03 | 0.01 | 0.01 | 0.04 |